MyBlueDotsMeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR MyBlueDots5 months ago01 mins ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)– #AMR–These new members bring decades of experience in medicine, industry, and healthcare policy, strengthening MeMed’s work in host-response technologies. Post navigation Previous: Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025Next: Syringe exchange fears hobble fight against West Virginia HIV outbreak
‘Master control switch’ protein that heightens neurodegenerative disease offers new treatment target MyBlueDots2 days ago 0
New findings reveal how the heart is organized from the earliest stages of embryonic development MyBlueDots2 days ago 0
Scholastic performance is a key concern for young cancer patients, study finds MyBlueDots2 days ago 0